相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Discovery and Characterization of GSK2801, a Selective Chemical Probe for the Bromodomains BAZ2A and BAZ2B
Peiling Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Discovery of a Chemical Tool Inhibitor Targeting the Bromodomains of TRIM24 and BRPF
James Bennett et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition
Natalie H. Theodoulou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Structure-Guided Design of IACS-9571, a Selective High-Affinity Dual TRIM24-BRPF1 Bromodomain Inhibitor
Wylie S. Palmer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Fragment-Based Design of Selective Nanomolar Ligands of the CREBBP Bromodomain
Andrea Unzue et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
NanoBRET-A Novel BRET Platform for the Analysis of Protein-Protein Interactions
Thomas Machleidt et al.
ACS CHEMICAL BIOLOGY (2015)
LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor
Peter G. K. Clark et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy
Sarah Picaud et al.
CANCER RESEARCH (2015)
The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNFMutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies
Bhavatarini Vangamudi et al.
CANCER RESEARCH (2015)
Transcriptional Profiling of a Selective CREB Binding Protein Bromodomain Inhibitor Highlights Therapeutic Opportunities
Eugene L. Piatnitski Chekler et al.
CHEMISTRY & BIOLOGY (2015)
Structure-Based Optimization of Naphthyridones into Potent ATAD2 Bromodomain Inhibitors
Paul Bamborough et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
9H-Purine Scaffold Reveals Induced-Fit Pocket Plasticity of the BRD9 Bromodomain
Sarah Picaud et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Structure Enabled Design of BAZ2-ICR, A Chemical Probe Targeting the Bromodomains of BAZ2A and BAZ2B
Ludovic Drouin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Fragment-Based Discovery of Low-Micromolar ATAD2 Bromodomain Inhibitors
Emmanuel H. Demont et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Design and synthesis of potent and selective inhibitors of BRD7 and BRD9 bromodomains
Duncan A. Hay et al.
MEDCHEMCOMM (2015)
Target (In)Validation: A Critical, Sometimes Unheralded, Role of Modern Medicinal Chemistry
Ramzi F. Sweis
ACS MEDICINAL CHEMISTRY LETTERS (2015)
BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cells
Marie-Magdelaine Coude et al.
ONCOTARGET (2015)
Selective targeting of the BRG/PB1 bromodomains impairs embryonic and trophoblast stem cell maintenance
Oleg Fedorov et al.
SCIENCE ADVANCES (2015)
Small Molecule Inhibitors of Bromodomain-Acetyl-lysine Interactions
Michael Brand et al.
ACS CHEMICAL BIOLOGY (2015)
A Series of Potent CREBBP Bromodomain Ligands Reveals an Induced-Fit Pocket Stabilized by a Cation-π Interaction
Timothy P. C. Rooney et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Bromodomains and Their Pharmacological Inhibitors
Daniel Gallenkamp et al.
CHEMMEDCHEM (2014)
BET bromodomain inhibitors: a patent review
Jean-Marc Garnier et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2014)
Phenotypic screening and fragment-based approaches to the discovery of small-molecule bromodomain ligands
Laura E. Jennings et al.
FUTURE MEDICINAL CHEMISTRY (2014)
[1,2,4]Triazolo[4,3-a]phthalazines: Inhibitors of Diverse Bromodomains
Oleg Fedorov et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Fragment-Based Screening of the Bromodomain of ATAD2
Mary J. Harner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Biased Multicomponent Reactions to Develop Novel Bromodomain Inhibitors
Michael R. McKeown et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains
Duncan A. Hay et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
A rationale to target the SWI/SNF complex for cancer therapy
Anja F. Hohmann et al.
TRENDS IN GENETICS (2014)
Structure-based approaches towards identification of fragments for the low-druggability ATAD2 bromodomain
Apirat Chaikuad et al.
MEDCHEMCOMM (2014)
Machine-assisted synthesis of modulators of the histone reader BRD9 using flow methods of chemistry and frontal affinity chromatography
Lucie Guetzoyan et al.
MEDCHEMCOMM (2014)
1,3-Dimethyl Benzimidazolones Are Potent, Selective Inhibitors of the BRPF1 Bromodomain
Emmanuel H. Demont et al.
ACS MEDICINAL CHEMISTRY LETTERS (2014)
Assessing cellular efficacy of bromodomain inhibitors using fluorescence recovery after photobleaching
Martin Philpott et al.
EPIGENETICS & CHROMATIN (2014)
Small-Molecule Modulators for Epigenetics Targets
Stefan Knapp et al.
CHEMMEDCHEM (2013)
Discovery of Epigenetic Regulator I-BET762: Lead Optimization to Afford a Clinical Candidate Inhibitor of the BET Bromodomains
Olivier Mirguet et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Targeting Low-Druggability Bromodomains: Fragment Based Screening and Inhibitor Design against the BAZ2B Bromodomain
Fleur M. Ferguson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Optimization of 3,5-Dimethylisoxazole Derivatives as Potent Bromodomain Ligands
David S. Hewings et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Structure-Guided Design of Potent Diazobenzene Inhibitors for the BET Bromodomains
Guangtao Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Target validation using chemical probes
Mark E. Bunnage et al.
NATURE CHEMICAL BIOLOGY (2013)
RVX-208, an Inducer of ApoA-I in Humans, Is a BET Bromodomain Antagonist
Kevin G. McLure et al.
PLOS ONE (2013)
High-Resolution Enabled TMT 8-plexing
Thilo Werner et al.
ANALYTICAL CHEMISTRY (2012)
From ApoA1 upregulation to BET family bromodomain inhibition: Discovery of I-BET151
Olivier Mirguet et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Identification of a novel series of BET family bromodomain inhibitors: Binding mode and profile of I-BET151 (GSK1210151A)
Jonathan Seal et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family
Panagis Filippakopoulos et al.
CELL (2012)
Epigenetic Chemical Probes
S. Mueller et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
The bromodomain interaction module
Panagis Filippakopoulos et al.
FEBS LETTERS (2012)
Druggability Analysis and Structural Classification of Bromodomain Acetyl-lysine Binding Sites
Lewis R. Vidler et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Fragment-Based Discovery of Bromodomain Inhibitors Part 1: Inhibitor Binding Modes and Implications for Lead Discovery
Chun-wa Chung et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Progress in the Development and Application of Small Molecule Inhibitors of Bromodomain-Acetyl-lysine Interactions
David S. Hewings et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Identification of a Chemical Probe for Bromo and Extra C-Terminal Bromodomain Inhibition through Optimization of a Fragment-Derived Hit
Paul V. Fish et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Epigenetic protein families: a new frontier for drug discovery
Cheryl H. Arrowsmith et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Place your BETs: the therapeutic potential of bromodomains
R. K. Prinjha et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
Inhibition of bromodomain-mediated protein-protein interactions as a novel therapeutic strategy
Silviya D. Furdas et al.
MEDCHEMCOMM (2012)
A Small Molecule Binding to the Coactivator CREB-Binding Protein Blocks Apoptosis in Cardiomyocytes
Jagat C. Borah et al.
CHEMISTRY & BIOLOGY (2011)
3,5-Dimethylisoxazoles Act As Acetyl-lysine-mimetic Bromodomain Ligands
David S. Hewings et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Discovery and Characterizatlion of Small Molecule Inhibitors of the BET Family Bromodomains
Chun-wa Chung et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Rational Design of Cyclic Peptide Modulators of the Transcriptional Coactivator CBP: A New Class of p53 Inhibitors
Guillermo Gerona-Navarro et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
Mark A. Dawson et al.
NATURE (2011)
Suppression of inflammation by a synthetic histone mimic
Edwige Nicodeme et al.
NATURE (2010)
Selective inhibition of BET bromodomains
Panagis Filippakopoulos et al.
NATURE (2010)
Functional characterization of ATAD2 as a new cancer/testis factor and a predictor of poor prognosis in breast and lung cancers
C. Caron et al.
ONCOGENE (2010)
Molecular Architecture of Quartet MOZ/MORF Histone Acetyltransferase Complexes
Mukta Ullah et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
Marcus Bantscheff et al.
NATURE BIOTECHNOLOGY (2007)
Structure and acetyl-lysine recognition of the bromodomain
S. Mujtaba et al.
ONCOGENE (2007)
Target structure-based discovery of small molecules that block human p53 and CREB binding protein association
Sachchidanand et al.
CHEMISTRY & BIOLOGY (2006)
Selective small molecules blocking HIV-1 Tat and coactivator PCAF association
L Zeng et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
Structural mechanism of the bromodomain of the coactivator CBP in p53 transcriptional activation
S Mujtaba et al.
MOLECULAR CELL (2004)
Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRGI, in lung tumors
PP Medina et al.
GENES CHROMOSOMES & CANCER (2004)
Structural basis of lysine-acetylated HIV-1 tat recognition by PCAF bromodomain
S Mujtaba et al.
MOLECULAR CELL (2002)
分享论文
